
|Articles|September 20, 2017
Lack of Trust Less of a Barrier to Clinical Trial Participation
Advertisement
In a recent public opinion survey commissioned by Research!America, the percentage of respondents including African-Americans, Hispanics, Asians and non-Hispanic whites who cited ‘lack of trust’ as a reason why they do not participate in clinical trials declined, thus showing that most of them feel other factors contribute to low participation rates.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Drug Repurposing Through AI-Driven In-Silico Clinical Trials
2
Former FDA Commissioners Warn New Vaccine Policies Could Undermine Longstanding Regulatory Framework
3
CNS and Autoimmune Trials: Growth and Operational Implications
4
ACT Brief: CNS Trial Expansion, Vaccine Policy Debate, and New Leadership at FDA
5





.png)



.png)



.png)
.png)
